Omid Veiseh

Dr. Omid Veiseh


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2022 in Nature Reviews Drug Discovery
Verified
Journal Article
Closed access
PDF file
CBCaleb J. Bashor
Caleb J. Bashor
IHIsaac B. Hilton
Isaac B. Hilton
HBHozefa Bandukwala
Hozefa Bandukwala
DSDevyn M. Smith
Devyn M. Smith
OVOmid Veiseh
Omid Veiseh

21 June 2021 in Nature Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
JDJoshua Doloff
Joshua Doloff
OVOmid Veiseh
Omid Veiseh
RMRoberto de Mezerville
Roberto de Mezerville
MSMarcos Sforza
Marcos Sforza
TPTracy Ann Perry
Tracy Ann Perry
RLRobert Langer
Robert Langer

20 March 2017 in Nature Materials
Verified
Journal Article
Open access
PDF file
JDJoshua Doloff
Joshua Doloff
OVOmid Veiseh
Omid Veiseh
AVArturo J. Vegas
Arturo J. Vegas
HTHok Hei Tam
Hok Hei Tam
SFShady Farah
Shady Farah
DADaniel G. Anderson
Daniel G. Anderson
Host recognition and immune-mediated foreign body response to biomaterials can compromise the performance of implanted medical devices. To identify key cell and cytokine targets, here we perform in-depth systems analysis of innate and adaptive immune system responses to implanted biomaterials in rodents and non-human primates. While macrophages are indispensable to the fibrotic cascade, surprisingly neutrophils and complement are not. Macrophages, via CXCL13, lead to downstream B cell recruitment, which further potentiated fibrosis, as confirmed by B cell knockout and CXCL13 neutralization. Interestingly, colony stimulating factor-1 receptor (CSF1R) is significantly increased following implantation of multiple biomaterial classes: ceramic, polymer and hydrogel. Its inhibition, like macrophage depletion, leads to complete loss of fibrosis, but spares other macrophage functions such as wound healing, reactive oxygen species production and phagocytosis. Our results indicate that targeting CSF1R may allow for a more selective method of fibrosis inhibition, and improve biomaterial biocompatibility without the need for broad immunosuppression.

1 April 2019 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
OVOmid Veiseh
Omid Veiseh
AVArturo J. Vegas
Arturo J. Vegas

30 July 2018 in Nature Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
XXXi Xie
Xi Xie
JDJoshua C. Doloff
Joshua C. Doloff
VYVolkan Yesilyurt
Volkan Yesilyurt
ASAtieh Sadraei
Atieh Sadraei
JMJames J. McGarrigle
James J. McGarrigle
DADaniel G. Anderson
Daniel G. Anderson

30 March 2020 in Nature Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
SBSuman Bose
Suman Bose
LVLisa R. Volpatti
Lisa R. Volpatti
DTDevina Thiono
Devina Thiono
VYVolkan Yesilyurt
Volkan Yesilyurt
CMCollin McGladrigan
Collin McGladrigan
DADaniel G. Anderson
Daniel G. Anderson